Gigxone-TZ 250 Injection
Marketer
Primero Life sciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Gigxone-TZ 250 Injection
Tazobactam and Cefixime Injection (250mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance; adhere to all scheduled doses. Complete the prescribed course, regardless of symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening effects necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor might order blood tests and imaging to monitor treatment response.
Primary Ingredients of Gigxone-TZ 250 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Gigxone-TZ 250 Injection
Infections caused by bacteria
Major Benefits of Gigxone-TZ 250 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Gigxone-TZ 250 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Gigxone-TZ 250 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Gigxone-TZ 250 Injection works:
Ceftriaxone and Tazobactum, combined as Gigxone-TZ 250 Injection, offer a potent antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Tazobactum, a beta-lactamase inhibitor, complements this action by neutralizing enzymes that would otherwise break down Ceftriaxone, thereby improving its effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Gigxone-TZ 250 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Gigxone-TZ 250 is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Gigxone-TZ 250 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until the mother's course of treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Gigxone-TZ 250 Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gigxone-TZ 250 Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Gigxone-TZ 250 Injection cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Dosage alteration for Gigxone-TZ 250 Injection is unnecessary in individuals with mild to moderate liver dysfunction.
What if you forget to take Gigxone-TZ 250 Injection :
Should you inadvertently omit a dose of Gigxone-TZ 250 Injection, seek advice from your physician.
Facts to Know About Gigxone-TZ 250 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently